PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $171,304,162.39
- Sept. 12, 2025
- Mark Elliott Boulding
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 7, 2022 | CFO | 800 | $38.52 | Sell | $30,816.00 | |
Jan. 7, 2022 | Insider | 756 | $38.52 | Sell | $29,121.12 | |
Jan. 7, 2022 | CAO | 747 | $38.52 | Sell | $28,774.44 | |
Jan. 7, 2022 | VP | 885 | $38.52 | Sell | $34,090.20 | |
Jan. 4, 2022 | Insider | 64 | $41.16 | Sell | $2,634.24 | |
Jan. 4, 2022 | CFO | 173 | $41.16 | Sell | $7,120.68 | |
Jan. 4, 2022 | CEO | 378 | $41.16 | Sell | $15,558.48 | |
Aug. 13, 2021 | Director | 1,650 | $40.06 | Sell | $66,099.00 | |
July 8, 2021 | VP | 7,805 | $45.22 | Sell | $352,942.10 | |
June 9, 2021 | Director | 365 | $41.88 | Sell | $15,286.20 | |
April 19, 2021 | Insider | 786 | $48.17 | Sell | $37,861.62 | |
Feb. 1, 2021 | CAO | 368 | $56.96 | Sell | $20,961.28 | |
Feb. 1, 2021 | CAO | 368 | $56.96 | Sell | $20,961.28 | |
Feb. 1, 2021 | Director | 506 | $56.96 | Sell | $28,821.76 | |
Feb. 1, 2021 | CFO | 541 | $56.96 | Sell | $30,815.36 | |
Feb. 1, 2021 | VP | 778 | $56.96 | Sell | $44,314.88 | |
Feb. 1, 2021 | Insider | 973 | $56.96 | Sell | $55,422.08 | |
Feb. 1, 2021 | CEO | 1,968 | $56.96 | Sell | $112,097.28 | |
Jan. 25, 2021 | CFO | 275 | $62.05 | Sell | $17,063.75 | |
Jan. 25, 2021 | Insider | 541 | $63.15 | Sell | $34,164.15 | |
Jan. 25, 2021 | CEO | 350 | $62.05 | Sell | $21,717.50 | |
Jan. 15, 2021 | Insider | 4,300 | $69.09 | Sell | $297,087.00 | |
Jan. 8, 2021 | CFO | 26,033 | $69.75 | Sell | $1,815,801.75 | |
Jan. 7, 2021 | Insider | 3,886 | $68.98 | Sell | $268,056.28 | |
Jan. 5, 2021 | CEO | 1,402 | $62.37 | Sell | $87,442.74 | |
Jan. 5, 2021 | CAO | 316 | $62.37 | Sell | $19,708.92 | |
Jan. 5, 2021 | CFO | 288 | $62.37 | Sell | $17,962.56 | |
Jan. 5, 2021 | insider | 1,067 | $62.37 | Sell | $66,548.79 | |
Jan. 5, 2021 | VP | 772 | $62.37 | Sell | $48,149.64 | |
Dec. 30, 2020 | CEO | 285,718 | $61.74 | Sell | $17,640,229.32 | |
Dec. 8, 2020 | Director | 687 | $62.52 | Sell | $42,951.24 | |
Dec. 7, 2020 | CEO | 348,417 | $61.00 | Sell | $21,253,437.00 | |
Nov. 4, 2020 | CEO | 49,365 | $60.00 | Sell | $2,961,900.00 | |
Nov. 4, 2020 | CAO | 31,758 | $60.06 | Sell | $1,907,385.48 | |
Nov. 3, 2020 | Insider | 6,194 | $56.50 | Sell | $349,961.00 | |
Nov. 2, 2020 | CEO | 50,000 | $53.66 | Sell | $2,683,000.00 | |
Oct. 16, 2020 | Director | 5,000 | $51.29 | Sell | $256,450.00 | |
Oct. 6, 2020 | CAO | 2,500 | $50.08 | Sell | $125,200.00 | |
Oct. 6, 2020 | CEO | 124,351 | $50.12 | Sell | $6,232,472.12 | |
July 15, 2020 | CEO | 100,000 | $55.70 | Sell | $5,570,000.00 | |
July 7, 2020 | VP | 30,625 | $55.12 | Sell | $1,688,050.00 | |
July 6, 2020 | CAO | 3,288 | $53.70 | Sell | $176,565.60 | |
June 29, 2020 | CFO | 2,581 | $52.50 | Sell | $135,502.50 | |
May 20, 2020 | CEO | 33,788 | $50.00 | Sell | $1,689,400.00 | |
May 5, 2020 | CEO | 109,928 | $50.34 | Sell | $5,533,775.52 | |
April 20, 2020 | Director | 17,900 | $51.04 | Sell | $913,616.00 | |
April 17, 2020 | Director | 2,100 | $50.16 | Sell | $105,336.00 | |
April 17, 2020 | CAO | 2,145 | $50.00 | Sell | $107,250.00 | |
April 3, 2020 | CAO | 787 | $44.31 | Sell | $34,871.97 | |
Jan. 23, 2020 | CEO | 423 | $53.25 | Sell | $22,524.75 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Stuart Walter Peltz, Mark Elliott Boulding, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Allan Steven Jacobson, Mark Rothera, Matthew B Klein, Claudia De Oliveira Ri Hirawat, David P Southwell, Lee Scott Golden, Marcio Souza, Pierre Gravier, Stephanie Okey, Dawn Svoronos, Shane William Charles Kovacs, Hbm Healthcare Investments (Ca, Michael Schmertzler, Emma Reeve, Jerome B Zeldis, David Southwell, Adam Koppel, Alethia Young, Matthew B. Klein, Michael Kranda, Michael L Kranda, Richard Aldrich, Robert J Spiegel, and Robert Spiegel
The most active insider trader at PTC Therapeutics Inc is Stuart Walter Peltz with 31 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on Sept. 12, 2025.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.